1. Underpinning research: (
Research that underpins investigations into the cause, development, detection, treatment and management of diseases, conditions and ill health.
)
|
1.1 Normal biological development and functioning (i.e. genes, molecular and biological pathways) |
1.2 Psychological and socioeconomic processes (i.e. health and well-being) |
1.3 Chemical and physical sciences (i.e. molecular modeling, chemical structures, bioengineering) |
1.4 Methodologies and measurements (i.e. statistical methods, mapping methodologies, biological/socioeconomic research methods) |
1.5 Resources and infrastructure (i.e. development/distribution of resources, cell lines, DNA banks, infrastructure to support research networks and centers) |
2. Aetiology: (
Identification of determinants that are involved in the cause, risk or development of diseases, conditions and ill health.
)
|
2.1 Biological and endogenous factors (i.e. risk factors liked to ethnicity, age, gender, gene products) |
2.2 Factors relating to physical environment (i.e. physical agents, environmental surroundings, radiation and pollution) |
2.3 Psychological, social, and economic factors (i.e. individual or group behaviors and lifestyle) |
2.4 Surveillance and distribution |
2.5 Research design and methodologies-under aetiology category (i.e. development and evaluation of novel research designs, new epidemiological research measurements) |
2.6 Resources and infrastructure (under aetiology category) |
3. Prevention of disease and conditions, and promotion of well-being: (
Research aimed at the primary prevention of disease, conditions or ill health, or promotion of well-being.
)
|
3.1 Primary prevention interventions to modify behaviors or promote well-being (i.e. risk behaviors associated with diet, tobacco use, alcohol, substance misuse) |
3.2 Interventions to alter physical and biological environmental risks (i.e. radiation, second hand smoke, physical and chemical agents) |
3.3 Nutrition and chemoprevention |
3.4 Vaccines |
3.5 Resources and infrastructure (prevention) |
4. Detection, screening and diagnosis: (
Discovery, development and evaluation of diagnostic, prognostic and predictive markers and technologies.
)
|
4.1 Discovery and preclinical testing of markers and technologies |
4.2 Evaluation of markers and technologies |
4.3 Influences and impact of screening and factors affecting uptake (i.e. attitudes and beliefs such as culture and religious practices, issues relating to gender/age/ethnicity, genetic counseling) |
4.4 Population screening programmes (i.e. feasibility studies, evaluation of effectiveness, benefits and economic evaluation) |
4.5 Resources and infrastructure (detection) |
5. Development of treatments and therapeutic interventions: (
Discovery and development of therapeutic interventions and testing in model systems and preclinical settings.
)
|
5.1 Identification and development of pharmaceuticals (i.e. drug screening, mechanism of action, pharmacogenetics) |
5.2 Discovery and development of cellular, tissue and gene therapies (i.e. gene therapy, stem cell therapy, development of delivery systems) |
5.3 Discovery and development of medical devices |
5.4 Development of surgical interventions |
5.5 Radiotherapy |
5.6 Resources and infrastructure (development of treatments) |
6. Evaluation of treatments and therapeutic interventions: (
Testing and evaluation of therapeutic interventions in clinical, community or applied settings.
)
|
6.1 Pharmaceuticals (i.e. phase I, II, III and IV trials) |
6.2 Clinical application and evaluation of cellular, tissue and gene therapies |
6.3 Clinical and applied application and evaluation of surgical interventions |
6.4 Radiotherapy |
6.5 Resources and infrastructure (evaluation of treatments) |
7. Management of diseases and conditions: (
Research into individual care needs and management of disease, and conditions or ill health.
)
|
7.1 Studies of patients and service user care needs |
7.2 Studies involving all issues related to palliative care and end of life care |
7.3 Management of diseases, ill health and conditions by health and social care professionals |
7.4 Resources and infrastructure (disease management) |
8. Health and social care services research: (
Research into the provision and delivery of health and social care services, health policy and studies of research design, measurements and methodologies.
)
|
8.1 Examining the organization and provision of health and social care services and evaluating factors affecting the quality of care |
8.2 Economic evaluation of health and social care interventions and delivery |
8.3 Policy, ethics and research governance |
8.4 Development of research designs and novel methodologies for health care including treatment, management and health services research |
8.5 Resources and infrastructure (health services) |